Search Results

Showing results 1 to 10 of approximately 13.

(refine search)
SORT BY: PREVIOUS / NEXT
Keywords:Rhode Island 

Report
Did the Medicaid Expansion Crowd Out Other Payment Sources for Medications for Opioid Use Disorder? Evidence from Rhode Island

Using information from the all-payer claims database for Rhode Island covering more than three-quarters of health insurance enrollees in the state from April 2011 through May 2019, this paper offers new measures of the association between the Medicaid expansion and the rate of receipt of buprenorphine and methadone for opioid use disorder (OUD). These robust measures adjust for the extent to which new Medicaid payments for these medications that started in 2014 crowded out payments from either non-Medicaid insurance or from non-insurance subsidies for the treatment of opioid abuse. We find ...
Current Policy Perspectives

Journal Article
Comments on 2000 benchmark revisions to regional employment data

New England Economic Indicators , Issue Apr , Pages i-vi

Journal Article
Will the tobacco settlement payments go up in smoke?

In December 1995, Massachusetts attorney general Scott Harshbarger filed a civil suit against the tobacco industry. The Commonwealths lawsuit charged that the tobacco industry had conducted research into the addictive properties of nicotine and used this research to willfully manipulate the nicotine level of cigarettes in order to addict smokers and increase cigarette sales. The lawsuit asked the court for damages to compensate the Commonwealth for expenditures paid to treat smoking-related illnesses. At the time this litigation was filed, Massachusetts was the fifth state in the nation to ...
Fiscal Facts , Issue Spr , Pages 1-5

Working Paper
Did the Affordable Care Act Affect Access to Medications for Opioid Use Disorder among the Already Insured? Evidence from the Rhode Island All-payer Claims Database

Previous research suggests that state Medicaid expansions implemented under the Patient Protection and Affordable Care Act (ACA) helped large numbers of patients suffering from opioid use disorder (OUD) gain access to life-saving medications, including buprenorphine. However, Medicaid expansions could have impeded access to care among individuals already enrolled in Medicaid, as new enrollees would have placed added demands on a limited supply of buprenorphine providers. Using a panel data set of medical claims from Rhode Island, we estimate the causal effects of the state’s January 2014 ...
Working Papers , Paper 21-17

Journal Article
Lessons from the Rhode Island banking crisis

The failure of the Rhode Island Share and Deposit Indemnity Corporation (RISDIC), a private insurance fund, and the closure of its 45 remaining member institutions froze the accounts of 300,000 individuals and 10 percent of all deposits in the state. While the closure of two institutions triggered RISDICs demise, flaws in both design and management had set the stage for failure and are the focus of this article. The authors group RISDICs problems into three categories: risk concentrations, control of the insurance fund by those it insured, and RISDICs inadequate regulatory oversight of ...
New England Economic Review , Issue May , Pages 3-12

Journal Article
Art's economic power in New England

Communities and Banking , Issue Spr , Pages 10-14

Journal Article
Comments on 2001 benchmark revisions to regional employment data

In March 2002, the U.S. Bureau of Labor Statistics (BLS) released revised state and regional employment data based on the 2001 benchmark, affecting data for 2000 and 2001. Contrary to the employment boost shown in last year's revisions, the 2002 revisions increased New England's measured employment levels slightly for 2000 and reduced them in nearly all states and industries for 2001. Furthermore, the revisions show that the recession that began in 2001 had a deeper impact on employment in the region than in the nation, as New England's year-end employment decreased for the first time in a ...
New England Economic Indicators , Issue Apr , Pages i-vi

Report
The Medicaid Expansion and the Uptake of Medication-assisted Treatment for Opioid Use Disorder: Evidence from the Rhode Island All-payer Claims Database, 2012–2018

This article uses the all-payer claims database for the state of Rhode Island to assess recent progress in the state toward the goal of expanding access to medication-assisted treatment (MAT) for opioid use disorder (OUD). The analysis highlights the role played by the Affordable Care Act (ACA) and the associated Medicaid expansion in furthering that goal. Using measures that account for changes in health insurance enrollment, we find that the MAT rate per 100,000 enrollees in Rhode Island effectively doubled between 2012 and 2018, while the prevalence of OUD in the sample also doubled over ...
Current Policy Perspectives

Journal Article
Statement to Congress, April 17, 1991 (failure of the Rhode Island Share and Deposit Indemnity Corporation)

Federal Reserve Bulletin , Issue Jun , Pages 425-430

Report
Medication-assisted Treatment for Opioid Use Disorder in Rhode Island: Who Gets Treatment, and Does Treatment Improve Health Outcomes?

Since the early 2000s Rhode Island has been among the states hardest hit by the opioid crisis. In response, the state has made it a priority to expand access to medication-assisted treatment (MAT) for opioid use disorder (OUD), which refers to the use of the FDA-approved medications methadone, buprenorphine, and/or naltrexone in conjunction with behavioral therapy. MAT is strongly supported by scientific evidence and endorsed by US public health officials and yet fails to reach many OUD patients. Using administrative data covering medical treatments and selected health outcomes for more than ...
New England Public Policy Center Research Report , Paper 20-3

FILTER BY year

FILTER BY Content Type

FILTER BY Jel Classification

I12 4 items

I13 4 items

I18 4 items

I14 3 items

FILTER BY Keywords

PREVIOUS / NEXT